A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/455 (2006.01) A61K 31/00 (2006.01) A61K 31/403 (2006.01) A61K 31/437 (2006.01) A61K 31/538 (2006.01) A61P 3/06 (2006.01)
Patent
CA 2525772
A method of treating atherosclerosis is disclosed wherein nicotinic acid or another nicotinic acid receptor agonist is administered to the patient in combination with a DP receptor antagonist. The DP receptor antagonist is administered to reduce, prevent or eliminate flushing that may otherwise occur.
L'invention porte sur une méthode de traitement de l'athérosclérose, dans laquelle l'acide nicotinique ou autre agoniste du récepteur de l'acide nicotinique est administré au patient en combinaison avec un antagoniste du récepteur de DP, ce dernier étant administré pour réduire, prévenir ou éliminer l'éventuelle apparition de bouffées vasomotrices.
Cheng Kang
Metters Kathleen M.
O'neill Gary
Waters M. Gerard
Gowling Lafleur Henderson Llp
Merck & Co. Inc.
Merck Frosst Canada Ltd.
Merck Sharp & Dohme Corp.
LandOfFree
Method of treating atherosclerosis, dyslipidemias and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating atherosclerosis, dyslipidemias and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating atherosclerosis, dyslipidemias and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1930455